Quantcast

Latest Clinical research Stories

2014-05-29 08:29:36

REDWOOD CITY, Calif., May 29, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that senior management will present a corporate overview on June 3rd. Presentation details are as follows: Jefferies Global Healthcare ConferenceDate: June 3, 2014Location: Grand Hyatt New YorkPresentation Time: 1:30...

2014-05-29 08:29:27

SYDNEY, May 29, 2014 /PRNewswire/ -- RNAi-based therapeutics company, Benitec Biopharma Limited (ASX: BLT) is pleased to announce that it has dosed the first patient in its 'first in man', Phase I/IIa clinical trial for TT-034, a ddRNAi-based therapeutic, designed to treat and potentially cure hepatitis C (HCV) with a single injection. Benitec Biopharma's CEO and Managing Director, Peter French said, "The commencement of this clinical trial of TT-034 represents a landmark in the Company's...

2014-05-28 23:16:04

On May 12, the FDA announced that Maquet Datascope Intra-Aortic Balloon Pumps are recalled due to failure of a fan assembly. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) May 28, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for Intra-Aortic Balloon Pumps. The FDA announced on May 12,...

2014-05-28 23:15:56

Transvaginal Mesh Attorneys Babbitt, Johnson, Osborne and Le Clainche explain the FDA proposal to reclassify surgical mesh to a “high risk” device for pelvic organ prolapse (POP). West Palm Beach, Florida (PRWEB) May 28, 2014 After six years and thousands of lawsuits for transvaginal mesh injuries, the U.S. Food and Drug Administration (FDA) is proposing to reclassify surgical mesh for pelvic organ prolapse (POP) repair to a “high-risk device.” A physician’s news service called,...

2014-05-28 23:15:37

Based on the FDA’s most recent recall guidance, devicemakers now have to wonder if their product enhancements are an acceptable product enhancement, a recall, a product enhancement that’s now considered a recall, or neither a product enhancement nor a recall. This webinar explains the differences on how current or future product enhancements might be viewed by FDA. Falls Church, VA (PRWEB) May 28, 2014 Medical Device Recall or Product Enhancement?: Understanding When to Submit a Part...

2014-05-28 23:11:33

Informative webinar will explore the impact of clinical labels design and execution on the patient and site experience. The live broadcast will take place on Tuesday, June 17, 2014 at 11:00 EDT (16:00 UK BST/ GMT +1). Toronto, Canada (PRWEB) May 28, 2014 Clinical label production is typically on the critical path to bringing an investigative drug to market for a simple reason: No clinical trial can take place without labels. Even if the protocol is approved, the investigational product...

2014-05-28 23:08:35

PatientsLikeMe co-founder, Pfizer executive and top regulator champion collaboration. Washington (PRWEB) May 28, 2014 Global innovators in pioneering drug development and access will lead the DIA 2014 50th Annual Meeting in San Diego from June 15 to 19. Freda C. Lewis-Hall, executive vice president and chief medical officer of Pfizer Inc., and Sandra Kweder, deputy director of the Office of New Drugs for the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research,...

2014-05-28 12:32:45

LONDON, May 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/transitional_cell_cancer_urothelial_cell_cancer_global_clinical_trials_review.html Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H1, 2014 SummaryGlobalData's clinical trial report, "Transitional...

2014-05-28 08:33:12

Using the Digital Ecosystem Is Subject of DIA China Presentation and Downloadable White Paper SHANGHAI, May 28, 2014 /PRNewswire/ -- inVentiv Clinical Trial Recruitment Solutions (iCTRS), created to accelerate trials, explained at the 6(th) Annual DIA China Meeting how China's digital ecosystem can be used to speed clinical trial recruitment. Ramita Tandon, senior vice president and General Manager of iCTRS, spoke before 1,400 attendees on "Enhancing Clinical Trial Quality with Internet...

2014-05-28 08:32:52

PHILADELPHIA, May 28, 2014 /PRNewswire-USNewswire/ -- Premier Research today announced the appointment of Martin Nicklasson, Ph.D., to its board of directors. http://photos.prnewswire.com/prnvar/20140528/91686 Nicklasson brings to Premier Research a wealth of international experience in the biopharmaceutical sector, both at the executive and at the board level. A native of Sweden with a doctoral degree from the University of Uppsala, Nicklasson held positions in pharmaceutical...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.